Abstract: Disclosed herein is a Zeta-bio composition for reactivating lyophilized probiotics by conferring a negative zeta-potential on the cell surface of the probiotics, the composition comprising as a reactivator at least one selected from the group consisting of L-lysine, L-ornithine, L-tyrosine, and L-histidine. The composition activates lyophilized probiotics by conferring a negative zeta-potential thereon, with the consequent improvement of intestinal survivability and adhesion in the lyophilized probiotics in addition to exhibiting a restorative effect from cell damage due to lyophilization.

Abstract: The present disclosure relates to a composition for screening an intestinal environment-improving material and a screening method using the composition, and according to the composition and the method of the present disclosure, it is possible to provide an effective analysis method for screening a microbiota-improving candidate material in a personalized manner by providing a method for verifying personalized probiotics, prebiotics, foods, health functional foods and drugs under in vitro conditions based on microbiota and microbiota metabolites.

Abstract: An isolated bacterial strain Bacillus amyloliquefaciens 298 is provided. A sample of the strain having been deposited as KCTC 13469BP at the Korean Collection for Type Cultures or a functional homolog of same wherein said isolated microbial strain is purified to a level of at least 99%. Also provided are compositions and articles comprising the bacterial strain and methods of using same.

Abstract: A composition comprising at least two bacterial strains selected from the group consisting of Bacillus subtilis 281, Bacillus subtilis 3, Bacillus amyloliquefaciens 298 and a functional homolog of any of the preceding, wherein the composition does not comprise more than 5 different species of microbes, wherein: a sample of Bacillus subtilis 281, has been deposited as KCTC 13468BP at the Korean Collection for Type Cultures; a sample of Bacillus subtilis 3, has been deposited as KCTC 13467BP at the Korean Collection for Type Cultures; and a sample of Bacillus amyloliquefaciens 298, has been deposited as KCTC 13469BP at the Korean Collection for Type Cultures. Also provided are methods that utilize the bacterial strains or functional homologs of same.

Abstract: An isolated bacterial strain Bacillus subtilis 281 or a functional homolog of same is provided. A sample has been deposited as KCTC 13468BP at the Korean Collection for Type Cultures, wherein the isolated microbial strain is purified to a level of at least 99%. Also provided are methods of using the isolated bacterial strain or the functional homolog of same.

Abstract: An isolated bacterial strain Bacillus subtilis 3 or a functional homolog of same is provided. A sample has been deposited as KCTC 13467BP at the Korean Collection for Type Cultures, wherein the isolated microbial strain is purified to a level of at least 99%. Also provided are methods of using the isolated bacterial strain or the functional homolog of same.

Abstract: The present disclosure relates to a composition for screening an intestinal environment-improving material and a screening method using the composition, and according to the composition and the method of the present disclosure, it is possible to provide an effective analysis method for screening a microbiota-improving candidate material in a personalized manner by providing a method for verifying personalized probiotics, prebiotics, foods, health functional foods and drugs under in vitro conditions based on microbiota and microbiota metabolites.

Abstract: The present disclosure relates to a composition for screening an intestinal environment-improving material and a screening method using the composition, and according to the composition and the method of the present disclosure, it is possible to provide an effective analysis method for screening a microbiota-improving candidate material in a personalized manner by providing a method for verifying personalized probiotics, prebiotics, foods, health functional foods and drugs under in vitro conditions based on microbiota and microbiota metabolites.

Abstract: The present disclosure relates to a composition for screening an intestinal environment-improving material and a screening method using the composition, and according to the composition and the method of the present disclosure, it is possible to provide an effective analysis method for screening a microbiota-improving candidate material in a personalized manner by providing a method for verifying personalized probiotics, prebiotics, foods, health functional foods and drugs under in vitro conditions based on microbiota and microbiota metabolites.

Abstract: An isolated bacterial strain Bacillus subtilis 3 or a functional homolog of same is provided. A sample has been deposited as KCTC 13467BP at the Korean Collection for Type Cultures, wherein the isolated microbial strain is purified to a level of at least 99%. Also provided are methods of using the isolated bacterial strain or the functional homolog of same.

Abstract: An isolated bacterial strain Bacillus subtilis 281 or a functional homolog of same is provided. A sample has been deposited as KCTC 13468BP at the Korean Collection for Type Cultures, wherein the isolated microbial strain is purified to a level of at least 99%. Also provided are methods of using the isolated bacterial strain or the functional homolog of same.

Abstract: A composition comprising at least two bacterial strains selected from the group consisting of Bacillus subtilis 281, Bacillus subtilis 3, Bacillus amyloliquefaciens 298 and a functional homolog of any of the preceding, wherein the composition does not comprise more than 5 different species of microbes, wherein: a sample of Bacillus subtilis 281, has been deposited as KCTC 13468BP at the Korean Collection for Type Cultures; a sample of Bacillus subtilis 3, has been deposited as KCTC 13467BP at the Korean Collection for Type Cultures; and a sample of Bacillus amyloliquefaciens 298, has been deposited as KCTC 13469BP at the Korean Collection for Type Cultures. Also provided are methods that utilize the bacterial strains or functional homologs of same.

Abstract: An isolated bacterial strain Bacillus amyloliquefaciens 298 is provided. A sample of the strain having been deposited as KCTC 13469BP at the Korean Collection for Type Cultures or a functional homolog of same wherein said isolated microbial strain is purified to a level of at least 99%. Also provided are compositions and articles comprising the bacterial strain and methods of using same.

Abstract: A composition including at least one selected from the group consisting of the APsulloc 331261 (accession number: KCCM11179P) strain of Lactobacillus plantarum, a lysed product thereof, a culture thereof, and an extract thereof is disclosed. The composition has an activity of improving or treating disorders of the digestive system caused by alcohol or inflammation to facilitate the recovery of and improve the welfare of relevant patients. A method of preventing, improving, or treating gastrointestinal disorders by using the composition is disclosed.

Abstract: The present invention relates to a Lactobacillus plantarum HAC01 strain having anti-inflammatory efficacy and metabolic disease improving efficacy, a probiotic preparation, an anti-inflammatory composition, and a health food composition for improving a metabolic disease, which comprises, as an active ingredient, at least one selected from the group consisting of the strain, a culture product of the strain, a concentrate of the culture product, and a dried material of the culture product.

Abstract: The present invention relates to a Lactobacillus plantarum HAC01 strain having anti-inflammatory efficacy and metabolic disease improving efficacy, a probiotic preparation, an anti-inflammatory composition, and a health food composition for improving a metabolic disease, which comprises, as an active ingredient, at least one selected from the group consisting of the strain, a culture product of the strain, a concentrate of the culture product, and a dried material of the culture product.